Madison Asset Management LLC Invests $2.65 Million in ICU Medical, Inc. $ICUI

Madison Asset Management LLC bought a new position in ICU Medical, Inc. (NASDAQ:ICUI) during the 2nd quarter, HoldingsChannel reports. The fund bought 18,088 shares of the medical instruments supplier’s stock, valued at approximately $2,652,000.

Several other hedge funds also recently made changes to their positions in ICUI. AQR Capital Management LLC raised its holdings in ICU Medical by 2.5% during the 1st quarter. AQR Capital Management LLC now owns 9,360 shares of the medical instruments supplier’s stock valued at $1,297,000 after buying an additional 229 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in ICU Medical by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,764 shares of the medical instruments supplier’s stock worth $1,772,000 after acquiring an additional 560 shares during the last quarter. United Services Automobile Association bought a new stake in ICU Medical in the 1st quarter worth $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of ICU Medical by 32.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 68,211 shares of the medical instruments supplier’s stock valued at $9,472,000 after acquiring an additional 16,680 shares during the period. Finally, Intech Investment Management LLC increased its position in shares of ICU Medical by 38.6% in the first quarter. Intech Investment Management LLC now owns 11,938 shares of the medical instruments supplier’s stock valued at $1,658,000 after acquiring an additional 3,326 shares during the period. 96.10% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at ICU Medical

In related news, insider Ben Sousa sold 2,250 shares of ICU Medical stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $178.32, for a total transaction of $401,220.00. Following the completion of the transaction, the insider directly owned 3,076 shares of the company’s stock, valued at $548,512.32. This trade represents a 42.25% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Elisha W. Finney sold 378 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $182.48, for a total transaction of $68,977.44. Following the sale, the director directly owned 4,871 shares in the company, valued at $888,860.08. The trade was a 7.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 16,974 shares of company stock valued at $3,085,844 over the last 90 days. 2.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently commented on ICUI. Jefferies Financial Group raised shares of ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Piper Sandler raised their target price on ICU Medical from $163.00 to $195.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. Zacks Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 28th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $200.00 price target on shares of ICU Medical in a research report on Friday, August 7th. Finally, Wall Street Zen upgraded ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, ICU Medical presently has a consensus rating of “Moderate Buy” and an average target price of $192.80.

ICU Medical Trading Down 2.5%

NASDAQ ICUI opened at $182.53 on Friday. The company has a quick ratio of 1.21, a current ratio of 2.43 and a debt-to-equity ratio of 0.56. ICU Medical, Inc. has a twelve month low of $112.50 and a twelve month high of $192.85. The firm has a market capitalization of $4.56 billion, a PE ratio of 154.69, a P/E/G ratio of 2.37 and a beta of 0.74. The stock’s 50 day moving average is $160.03 and its 200 day moving average is $142.86.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.46. The business had revenue of $547.88 million during the quarter, compared to the consensus estimate of $533.44 million. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.10 earnings per share. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Research analysts forecast that ICU Medical, Inc. will post 7.19 earnings per share for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.